This curtain would possibly not be published, broadcast, rewritten, or redistributed. © 2025 Fox News Network, LLC. All Rights Reserved. Frequently Asked Questions – New Privacy Policy
Merck CEO Robert Davis joins the mornings with Maria’ to talk about the new billion-dollar biology production facility to be built in Wilmington, Delaware, and brought back to the United States
Thousands of jobs may be on the horizon for U. S. personnel, as drugmaker Merck moves to move production to the U. S. Especially in the form of a billion-dollar biocenter under structure in Wilmington, Delaware.
In a Fox Business exclusive, Robert Davis, the company’s CEO, told “Mornings with Maria,” the effort will take time as Merck builds capacity, however, the profit may mean solid for drugs in addition to high-paying jobs.
Davis said Merck has recently contracted production for the drug substance in the United States as well as outside the U. S. gates, however, the company must have a substance and product in the U. S. U. S. In the U. S.
A guy from India was arrested in Texas for allegedly promoting fake cancer remedy drugs to others in the United States
The firm outside the gates of Merck’s headquarters in Kenilworth, New Jersey, USA. On Monday, January 25, 2021. (Christopher Occicone/Bloomberg/Getty Images)
“For Ireland, what that means is not necessarily that we’re going to close down operations, because we still have to serve the rest of the world, too,” he explained on Tuesday.
“This is really an opportunity for us to [have the] U.S. [provide] for [the] U.S., [and] Europe [provide] for Europe, and have a much more risk-mitigated, resilient supply chain that has optionality that allows us to bring security. And as we think about national security, this is important security to the drug supply in the United States so that we can ensure that no matter what the situation is, U.S. patients get access to medicine.”
HOW TRUMP’S TARIFFS COULD IMPACT THE LABOR MARKET
Merck manufactures popular drugs like KEYTRUDA, a immunotherapy drug used for cancer treatment. (Lindsey Nicholson/UCG/Universal Images Group via Getty Images / Getty Images)
A news release from the company states Merck Wilmington Biotech will “comprise laboratory, manufacturing and warehouse capabilities to enable the launch and commercial production of next-generation biologics and therapies including potent antibody-drug conjugates (ADCs), reinforcing Merck’s focus on expanding and diversifying its pipeline.”
The site will also have production capabilities for the popular immunotherapy drug KEYTRUDA, which is used to treat cancer.
CLICK HERE TO GET FOX BUSINESS ON THE GO
President Trump accused Ireland of luring in American pharmaceutical companies, taking revenue and jobs from the U.S. because of its low corporate tax rate.
Davis said the location could initially provide 4,000 construction jobs and 500 full-time positions but expand to a workforce of 2,000 with 30,000 construction workers.
“It will be a meaningful opportunity both for tradesmen and for manufacturing to have good, high-quality paying jobs here in the United States,” he added.
This curtain would possibly not be published, broadcast, rewritten, or redistributed. © 2025 Fox News Network, LLC. All Rights Reserved. Frequently Asked Questions – New Privacy Policy